Showing results (61-70 of 99) with videos related to
Sort By:
Pageof 10
Current Pharmaceutical Design|April 14, 2004
High-throughput structural biology in drug discovery: protein kinasesT J Stout, P G Foster, D J MatthewsEuropean Journal of Immunology|January 1, 1990
Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generationM Finney, G R Guy, R H Michell, et al.European Journal of Immunology|August 1, 1986
B cell growth and differentiation induced by supernatants of transformed epithelial cell linesF C Rawle, J Shields, S H Smith, et al.Immunology|November 1, 1988
The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23)R E Callard, Y L Lau, J G Shields, et al.European Journal of Immunology|April 1, 1987
The response of selected human B cell lines to B cell growth and differentiation factorsJ G Shields, S H Smith, R J Levinsky, et al.Developmental Dynamics : an Official Publication of the American Association of Anatomists|September 1, 1996
Transferrin and its receptor in the development of genetically determined neural tube defects in the mouse embryoC Hoyle, D J Henderson, D J Matthews, et al.Biochemistry|July 29, 2000
Structures of active and latent PAI-1: a possible stabilizing role for chloride ionsT J Stout, H Graham, D I Buckley, et al.European Journal of Immunology|February 1, 1988
Response of LFA-1-deficient B cells to interleukin 4 (BSF-1) and low molecular weight B cell growth factor (BCGFlow)J G Shields, S H Smith, S Strobel, et al.British Journal of Haematology|May 1, 1981
Abnormalities of T-cell subsets in patients with neutropenia and an excess of lymphocytes in the bone marrowD C Linch, J C Cawley, C P Worman, et al.Proceedings of the National Academy of Sciences of the United States of America|September 3, 1996
A sequential dimerization mechanism for erythropoietin receptor activationD J Matthews, R S Topping, R T Cass, et al.Pageof 10